These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31167350)

  • 1. Critical Success Factors of a Drug Traceability System for Creating Value in a Pharmaceutical Supply Chain (PSC).
    Silva RBD; Mattos CA
    Int J Environ Res Public Health; 2019 Jun; 16(11):. PubMed ID: 31167350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the critical success factors for implementing industry 4.0 in the pharmaceutical industry: Implications for supply chain sustainability in emerging economies.
    Debnath B; Shakur MS; Bari ABMM; Saha J; Porna WA; Mishu MJ; Islam ARMT; Rahman MA
    PLoS One; 2023; 18(6):e0287149. PubMed ID: 37319165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Makes a National Pharmaceutical Track and Trace System Succeed? Lessons From Turkey.
    Parmaksiz K; Pisani E; Kok MO
    Glob Health Sci Pract; 2020 Sep; 8(3):431-441. PubMed ID: 33008856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Success Factors and Traceability Technologies for Establishing a Safe Pharmaceutical Supply Chain.
    Haji M; Kerbache L; Sheriff KMM; Al-Ansari T
    Methods Protoc; 2021 Nov; 4(4):. PubMed ID: 34842786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing supply chain uncertainty and risk in the pharmaceutical industry.
    Wang M; Jie F
    Health Serv Manage Res; 2020 Aug; 33(3):156-164. PubMed ID: 31213085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods.
    Jaberidoost M; Olfat L; Hosseini A; Kebriaeezadeh A; Abdollahi M; Alaeddini M; Dinarvand R
    J Pharm Policy Pract; 2015; 8(1):9. PubMed ID: 25838919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockchain for drug traceability: Architectures and open challenges.
    Uddin M; Salah K; Jayaraman R; Pesic S; Ellahham S
    Health Informatics J; 2021; 27(2):14604582211011228. PubMed ID: 33899576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arkansas prescription monitoring program implemented.
    Robertson D
    J Ark Med Soc; 2013 Jun; 109(13):278-9. PubMed ID: 23808093
    [No Abstract]   [Full Text] [Related]  

  • 9. Supply Chain Challenges in Pharmaceutical Manufacturing Companies: Using Qualitative System Dynamics Methodology.
    Moosivand A; Rajabzadeh Ghatari A; Rasekh HR
    Iran J Pharm Res; 2019; 18(2):1103-1116. PubMed ID: 31531092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving End-to-End Traceability and Pharma Supply Chain Resilience using Blockchain.
    Sim C; Zhang H; Chang ML
    Blockchain Healthc Today; 2022; 5():. PubMed ID: 36779026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An application of multi-criteria decision-making approach to sustainable drug shortages management: evidence from a developing country.
    Moosivand A; Rangchian M; Zarei L; Peiravian F; Mehralian G; Sharifnia H
    J Pharm Health Care Sci; 2021 Apr; 7(1):14. PubMed ID: 33795021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Product Development in the Pharmaceutical Industry: Evidence from a generic market.
    Yousefi N; Mehralian G; Rasekh HR; Yousefi M
    Iran J Pharm Res; 2017; 16(2):834-846. PubMed ID: 28979339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockchain Medledger: Hyperledger fabric enabled drug traceability system for counterfeit drugs in pharmaceutical industry.
    Uddin M
    Int J Pharm; 2021 Mar; 597():120235. PubMed ID: 33549813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuity and change in the drug supply chain: actors, actions, and aversions.
    Mendoza RL
    J Med Econ; 2021; 24(1):689-697. PubMed ID: 33941029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Ethereum-Based Distributed Application for Enhancing Food Supply Chain Traceability.
    Kechagias EP; Gayialis SP; Papadopoulos GA; Papoutsis G
    Foods; 2023 Mar; 12(6):. PubMed ID: 36981145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland.
    Heiskanen K; Ahonen R; Kanerva R; Karttunen P; Timonen J
    PLoS One; 2017; 12(6):e0179479. PubMed ID: 28658307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interval valued intuitionistic fuzzy analytic hierarchy process-based green supply chain resilience evaluation methodology in post COVID-19 era.
    Ayyildiz E
    Environ Sci Pollut Res Int; 2023 Mar; 30(15):42476-42494. PubMed ID: 34669128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries.
    Pagliusi S; Madrid Y; Bramanti Y; Wilmansyah T; Yu H; Acebal A; Krishnamurthy KR; Raju Pinnamaraju V; Jadhav P; Park R; Yang L
    Vaccine X; 2023 Dec; 15():100366. PubMed ID: 37663047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A DECADE OF HEALTH TECHNOLOGY ASSESSMENT IN POLAND.
    Lipska I; McAuslane N; Leufkens H; Hövels A
    Int J Technol Assess Health Care; 2017 Jan; 33(3):350-357. PubMed ID: 28720170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.